兆科眼科有限公司（兆科眼科-B，股份代号：06622）于2026年7月9日公告，于香港联合交易所场内回购公司股份8,500股，占已发行股本约0.0015%，回购价格介乎每股港币2.58元至2.62元，合计支付约2.21万港元。根据翌日披露报表，本次回购后公司已发行股本仍为548,749,012股，暂未产生库藏股变动。
公司于2026年5月15日通过购回授权，可购回最多54,874,901股。截至目前，公司已根据授权在相关交易所合计回购1,719,500股，占购回授权通过当日已发行股本约3.1335%。公司确认本次回购已获得董事会正式授权，遵守了香港联合交易所证券上市规则及相关法律规定。公告由董事李小羿签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.